Хірургічне втручання у пацієнтів, які проходять антитромбоцитарну терапію 2 страница

42. Long J, Luckraz H, Thekkudan J, Maher A, Norell M. Heart Team discussion in managing­patients with coronary artery disease: outcome and reproducibility. Interact­Cardiovasc Thorac Surg 2012;14(5):594–598

43. Sobolev BG, Fradet G, Kuramoto L, Rogula B. The occurrence of adverse events in­relation to time after registration for coronary artery bypass surgery: a populationbased­observational study. J Cardiothorac Surg 2013;8:74

44. Graham MM, Knudtson ML, O’Neill BJ, Ross DB. Treating the right patient at the­right time: Access to cardiac catheterization, percutaneous coronary intervention­and cardiac surgery. Can J Cardiol 2006;22(8):679–683

45. Hannan EL, Samadashvili Z, Walford G, Holmes DR, Jacobs A, Sharma S, Katz S,­King SB 3rd. Predictors and outcomes of ad hoc vs. non-ad hoc percutaneous coronary­interventions. JACC Cardiovasc Interv 2009;2(4):350–356

46. Nallamothu BK, Krumholz HM. Putting ad hoc PCI on pause. JAMA 2010;304(18):­2059–2060

47. Montalescot G, Sechtem U, Achenbach S, Andreotti F, Arden C, Budaj A,­Bugiardini R, Crea F, Cuisset T, Di Mario C, Ferreira JR, Gersh BJ, Gitt AK,­Hulot JS, Marx N, Opie LH, Pfisterer M, Prescott E, Ruschitzka F, Sabate M, Senior R,­Taggart DP, van der Wall EE, Vrints CJ, Zamorano JL, Baumgartner H, Bax JJ,­Bueno H, Dean V, Deaton C, Erol C, Fagard R, Ferrari R, Hasdai D, Hoes AW,­Kirchhof P, Knuuti J, Kolh P, Lancellotti P, Linhart A, Nihoyannopoulos P,­Piepoli MF, Ponikowski P, Sirnes PA, Tamargo JL, Tendera M, Torbicki A,­Wijns W, Windecker S, Valgimigli M, Claeys MJ, Donner-Banzhoff N, Frank H,­Funck-Brentano C, Gaemperli O, Gonzalez-Juanatey JR, Hamilos M, Husted S,­James SK, Kervinen K, Kristensen SD, Maggioni AP, Pries AR, Romeo F, Ryden L,­Simoons ML, Steg PG, Timmis A, Yildirir A. 2013 ESC guidelines on the management­of stable coronary artery disease: The Task Force on the management of­stable coronary artery disease of the European Society of Cardiology. Eur Heart J­2013;34(38):2949–3003

48. Knuuti J, Bengel F, Bax JJ, Kaufmann PA, Le Guludec D, Perrone Filardi P, Marcassa C,­Ajmone Marsan N, Achenbach S, Kitsiou A, Flotats A, Eeckhout E, Minn H, Hesse BRisks and benefits of cardiac imaging: an analysis of risks related to imaging for coronary­artery disease. Eur Heart J 2014;35(10):633–638

48a. Amsterdam EA, Kirk JD, Bluemke DA, Diercks D, Farkouh ME, Garvey JL, Kontos MC, McCord J, Miller TD, Morise A, Newby LK, Ruberg FL, Scordo KA, Thompson PD. Testing of low-risk patients presenting to the emergency department with chest pain: a scientific statement from the American Heart Association. Circulation 2010;122:1756–1776.

49. Hulten E, Villines TC, Cheezum MK, Berman DS, Dunning A, Achenbach S,­Al-Mallah M, Budoff MJ, Cademartiri F, Callister TQ, Chang HJ, Cheng VY,­Chinnaiyan K, Chow BJ, Cury RC, Delago A, Feuchtner G, Hadamitzky M,­Hausleiter J, Kaufmann PA, Karlsberg RP, Kim YJ, Leipsic J, Lin FY, Maffei E,­Plank F, Raff GL, Labounty TM, Shaw LJ, Min JK, Investigators C. Usefulness of coronary­computed tomography angiography to predict mortality and myocardial infarction­among Caucasian, African and East Asian ethnicities (from the CONFIRM­[Coronary CT Angiography Evaluation for Clinical Outcomes: An International­Multicenter] Registry). Am J Cardiol 2013;111(4):479–485

50. Tonino PA, De Bruyne B, Pijls NH, Siebert U, Ikeno F, van’t Veer M, Klauss V,­Manoharan G, Engstrom T, Oldroyd KG, Ver Lee PN, MacCarthy PA,­Fearon WF, Investigators FS. Fractional flow reserve vs. angiography for guiding­percutaneous coronary intervention. N Engl J Med 2009;360(3):213–224

50a. Diamond GA.Aclinically relevant classification of chest discomfort. JAmColl Cardiol 1983;1:574–575.

51. Pijls NH, van Schaardenburgh P, Manoharan G, Boersma E, Bech JW, van’t Veer M,­Bar F, Hoorntje J, Koolen J, WijnsW, de Bruyne B. Percutaneous coronary intervention­of functionally nonsignificant stenosis: 5-year follow-up of the DEFER StudyJ Am Coll Cardiol 2007;49(21):2105–2111

51a. Lanza GA, Sestito A, Sgueglia GA, Infusino F, Manolfi M, Crea F, Maseri A. Current clinical features, diagnostic assessment and prognostic determinants of patients with variant angina. Int J Cardiol 2007;118:41–47.

52. Botman KJ, Pijls NH, Bech JW, Aarnoudse W, Peels K, van Straten B, Penn O,­Michels HR, Bonnier H, Koolen JJ. Percutaneous coronary intervention or bypass­surgery in multivessel disease? A tailored approach based on coronary pressure­measurement. Catheter Cardiovasc Interv 2004;63(2):184–191

53. Toth G,DeBruyne B, Casselman F,DeVroey F, Pyxaras S, Di Serafino L, Van Praet F,­Van Mieghem C, Stockman B, Wijns W, Degrieck I, Barbato E. Fractional flow­reserve-guided vs. angiography-guided coronary artery bypass graft surgery. Circulation­2013;128(13):1405–1411

54. De Bruyne B, Pijls NH, Kalesan B, Barbato E, Tonino PA, Piroth Z, Jagic N,­Mobius-Winkler S, Rioufol G, Witt N, Kala P, MacCarthy P, Engstrom T,­Oldroyd KG, Mavromatis K, Manoharan G, Verlee P, Frobert O, Curzen N,­Johnson JB, Juni P, Fearon WF, Investigators FT. Fractional flow reserve-guided­PCI vs. medical therapy in stable coronary disease. N Engl J Med 2012;367(11):­991–1001

55. Allman KC, Shaw LJ, Hachamovitch R, Udelson JE. Myocardial viability testing and­impact of revascularization on prognosis in patients with coronary artery disease­and left ventricular dysfunction: a meta-analysis. J Am Coll Cardiol 2002;39(7):­1151–1158

56. Beanlands RS, Nichol G, Huszti E, Humen D, Racine N, Freeman M, Gulenchyn KY,­Garrard L, deKemp R, Guo A, Ruddy TD, Benard F, Lamy A, Iwanochko RM, Investigators­P-. F-18-fluorodeoxyglucose positron emission tomography­imaging-assisted management of patients with severe left ventricular dysfunction­and suspected coronary disease: a randomized, controlled trial (PARR-2). J Am­Coll Cardiol 2007;50(20):2002–2012

56a. Madjid M, Fatemi O. Components of the complete blood count as risk predictors for coronary heart disease: in-depth review and update. Tex Heart Inst J 2013;40: 17–29.

.

57. Meijboom WB, Meijs MF, Schuijf JD, Cramer MJ, Mollet NR, van Mieghem CA,­Nieman K, van Werkhoven JM, Pundziute G, Weustink AC, de Vos AM,­Pugliese F, Rensing B, Jukema JW, Bax JJ, Prokop M, Doevendans PA, Hunink MG,­Krestin GP, de Feyter PJ. Diagnostic accuracy of 64-slice computed tomography­coronary angiography: a prospective, multicenter, multivendor study. J Am Coll­Cardiol 2008;52(25):2135–2144

57a. Ryden L. ESC Guideline diabetes 2013. Eur Heart J 2013

58. Miller JM, Rochitte CE, Dewey M, Arbab-Zadeh A, Niinuma H, Gottlieb I, Paul N,­Clouse ME, Shapiro EP, Hoe J, Lardo AC, Bush DE, de Roos A, Cox C, Brinker J,­Lima JA. Diagnostic performance of coronary angiography by 64-row CT. N Engl­J Med 2008;359(22):2324–2336

59. Sarno G, Decraemer I, Vanhoenacker PK, De Bruyne B, Hamilos M, Cuisset T,­Wyffels E, Bartunek J, Heyndrickx GR, WijnsW. On the inappropriateness of noninvasive­multidetector computed tomography coronary angiography to trigger­coronary revascularization: a comparison with invasive angiography. JACC Cardiovasc­Interv 2009;2(6):550–557

60. Schuijf JD, WijnsW, Jukema JW, Decramer I, Atsma DE, de Roos A, Stokkel MP,­Dibbets-Schneider P, van der Wall EE, Bax JJ. A comparative regional analysis of­coronary atherosclerosis and calcium score on multislice CT vs. myocardial perfusion­on SPECT. J Nucl Med 2006;47(11):1749–55

61. Budoff MJ, Dowe D, Jollis JG, Gitter M, Sutherland J, Halamert E, Scherer M,­Bellinger R, Martin A, Benton R, Delago A, Min JK. Diagnostic performance of­64-multidetector row coronary computed tomographic angiography for evaluation­of coronary artery stenosis in individuals without known coronary artery­disease: results from the prospective multicenter ACCURACY (Assessment by­Coronary Computed Tomographic Angiography of Individuals Undergoing Invasive­Coronary Angiography) trial. J Am Coll Cardiol 2008;52(21):1724–1732

62. Neglia D, Rovai D, Caselli C, Kaufmann P, Lombardi M, Lorenzoni V, Marinelli M,­Nekolla D, Pietila M, Scholte A, Sicari R, Teresinska A, Zamorano J,­Underwood R, Knuuti J, For the EVINCI Investigators. Detection of obstructive­coronary artery disease by non invasive anatomical and functional imaging Results of the multicenter European EVINCI study. Circulation 2013

62a. Reiner Z, Catapano AL, De Backer G, Graham I, Taskinen MR, Wiklund O, Agewall S, Alegria E, Chapman MJ, Durrington P, Erdine S, Halcox J, Hobbs R, Kjekshus J, Filardi PP, Riccardi G, Storey RF, Wood D, Bax J, Vahanian A, Auricchio A, Baumgartner H, Ceconi C, Dean V, Deaton C, Fagard R, Filippatos G, Funck-Brentano C, Hasdai D, Hoes A, Kearney P, Knuuti J, Kolh P, McDonagh T, Moulin C, Poldermans D, Popescu BA, Sechtem U, Sirnes PA, Tendera M, Torbicki A, Vardas P, Widimsky P, Windecker S, Berkenboom G, De Graaf J, Descamps O, Gotcheva N, Griffith K, Guida GF, Gulec S, Henkin Y, Huber K, Kesaniemi YA, Lekakis J, Manolis AJ, Marques-Vidal P, Masana L, McMurray J, Mendes M, Pagava Z, Pedersen T, Prescott E, Rato Q, Rosano G, Sans S, Stalenhoef A, Tokgozoglu L, Viigimaa M, Wittekoek ME, Zamorano JL. ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). Eur Heart J 2011;32:1769–1818.

63. Elhendy A, Shub C, McCully RB, Mahoney DW, Burger KN, Pellikka PA. Exercise­echocardiography for the prognostic stratification of patients with low pretest­probability of coronary artery disease. Am J Med 2001;111(1):18–23

63a. Sedlis SP, Jurkovitz CT, Hartigan PM, Goldfarb DS, Lorin JD, Dada M, Maron DJ, Spertus JA, Mancini GB, Teo KK, O’Rourke RA, Boden WE, Weintraub WS. Optimal medical therapy with or without percutaneous coronary intervention for patients with stable coronary artery disease and chronic kidney disease. Am J Cardiol 2009;104:1647–1653.

64. Elhendy A, MahoneyDW, Burger KN, McCully RB, Pellikka PA. Prognostic value of­exercise echocardiography in patients with classic angina pectoris. Am J Cardiol­2004;94(5):559–563

64a. Reddan DN, Szczech LA, Tuttle RH, Shaw LK, Jones RH, Schwab SJ, Smith MS, Califf RM, Mark DB, OwenWFJr. Chronic kidney disease, mortality, and treatment strategies among patients with clinically significant coronary artery disease. JAmSoc Nephrol 2003;14:2373–2380.

65. Sicari R, Pasanisi E, Venneri L, Landi P, Cortigiani L, Picano E, Echo Persantine International­Cooperative Study G, Echo Dobutamine International Cooperative­Study G. Stress echo results predict mortality: a large-scale multicenter prospective­international study. J Am Coll Cardiol 2003;41(4):589–595

65a. Di Angelantonio E, Chowdhury R, Sarwar N, Aspelund T, Danesh J, Gudnason V. Chronic kidney disease and risk of major cardiovascular disease and non-vascular mortality: prospective population based cohort study. BMJ 2010;341:c4986

66. Giri S, Shaw LJ, Murthy DR, Travin MI, Miller DD, Hachamovitch R, Borges-Neto S,­Berman DS, Waters DD, Heller GV. Impact of diabetes on the risk stratification­using stress single-photon emission computed tomography myocardial perfusion­imaging in patients with symptoms suggestive of coronary artery disease. Circulation­2002;105(1):32–40

66a. CockcroftDW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976;16:31–41.

67. Mc Ardle BA, Dowsley TF, deKemp RA, Wells GA, Beanlands RS. Does­rubidium-82 PET have superior accuracy to SPECT perfusion imaging for the diagnosis­of obstructive coronary disease?: A systematic reviewand meta-analysis. J Am­Coll Cardiol 2012;60(18):1828–1837

68. ShawLJ,Hendel R, Borges-Neto S, Lauer MS, Alazraki N, Burnette J, Krawczynska E,­Cerqueira M, Maddahi J, Myoview Multicenter R. Prognostic value of normal exercise­and adenosine (99m)Tc-tetrofosmin SPECT imaging: results from the multicenter­registry of 4,728 patients. J Nucl Med 2003;44(2):134–139

69. Bateman TM, Heller GV, McGhie AI, Friedman JD, Case JA, Bryngelson JR,­Hertenstein GK, Moutray KL, Reid K, Cullom SJ. Diagnostic accuracy of rest/­stress ECG-gated Rb-82 myocardial perfusion PET: comparison with ECG-gated­Tc-99m sestamibi SPECT. J Nucl Cardiol 2006;13(1):24–33

70. Parker MW, Iskandar A, Limone B, Perugini A, Kim H, Jones C, Calamari B,­Coleman CI, Heller GV. Diagnostic accuracy of cardiac positron emission tomography­vs. single photon emission computed tomography for coronary artery­disease: a bivariate meta-analysis. Circ Cardiovasc Imaging 2012;5(6):700–707

71. Nandalur KR, Dwamena BA, Choudhri AF, Nandalur MR, Carlos RC. Diagnostic­performance of stress cardiac magnetic resonance imaging in the detection of coronary­artery disease: a meta-analysis. J Am Coll Cardiol 2007;50(14):1343–1353

72. Schwitter J, Wacker CM, van Rossum AC, Lombardi M, Al-Saadi N, Ahlstrom H,­Dill T, Larsson HB, Flamm SD, Marquardt M, Johansson L. MR-IMPACT: comparison­of perfusion-cardiac magnetic resonance with single-photon emission computed­tomography for the detection of coronary artery disease in a multicentre,­multivendor, randomized trial. Eur Heart J 2008;29(4):480–489

73. Schwitter J,Wacker CM, Wilke N, Al-Saadi N, Sauer E, Huettle K, Schonberg SO,­Luchner A, Strohm O, Ahlstrom H, Dill T, Hoebel N, Simor T, Investigators M-IMR-IMPACT II: Magnetic Resonance Imaging for Myocardial Perfusion Assessment­in Coronary artery disease Trial: perfusion-cardiac magnetic resonance vs. singlephoton­emission computed tomography for the detection of coronary artery­disease: a comparative multicentre, multivendor trial. Eur Heart J 2013;34(10):­775–781

74. Jahnke C, Nagel E, Gebker R, KokocinskiT, Kelle S, Manka R, Fleck E, Paetsch I. Prognostic­value of cardiac magnetic resonance stress tests: adenosine stress perfusion­and dobutamine stress wall motion imaging. Circulation 2007;115(13):1769–1776

75. Korosoglou G, Elhmidi Y, Steen H, Schellberg D, Riedle N, Ahrens J, Lehrke S,­Merten C, Lossnitzer D, Radeleff J, Zugck C, Giannitsis E, Katus HA. Prognostic­value of high-dose dobutamine stress magnetic resonance imaging in 1,493 consecutive­patients: assessment of myocardial wall motion and perfusion. J Am Coll­Cardiol 2010;56(15):1225–1234

76. Dorbala S, Di Carli MF, Beanlands RS, Merhige ME, Williams BA, Veledar E,­Chow BJ, Min JK, Pencina MJ, Berman DS, Shaw LJ. Prognostic value of stress myocardial­perfusion positron emission tomography: results from a multicenter observational­registry. J Am Coll Cardiol 2013;61(2):176–184

77. Murthy VL, Naya M, Foster CR, Gaber M, Hainer J, Klein J, Dorbala S, Blankstein R,­Di Carli MF. Association between coronary vascular dysfunction and cardiac­mortality in patients with and without diabetes mellitus. Circulation 2012;126(15):­1858–1868

78. Kajander S, Joutsiniemi E, Saraste M, Pietila M, Ukkonen H, Saraste A, Sipila HT,­Teras M, Maki M, Airaksinen J, Hartiala J, Knuuti J. Cardiac positron emission tomography/­computed tomography imaging accurately detects anatomically and functionally­significant coronary artery disease. Circulation 2010;122(6):603–613

78a. Androulakis A, Aznaouridis KA, Aggeli CJ, Roussakis GN, Michaelides AP, Kartalis AN, Stougiannos PN, Dilaveris PE, Misovoulos PI, Stefanadis CI, Kallikazaros IE. Transient ST-segment depression during paroxysms of atrial fibrillation in otherwise normal individuals: relation with underlying coronary artery disease. J Am Coll Cardiol 2007;50:1909–1911.

79. Pazhenkottil AP, Nkoulou RN, Ghadri JR, Herzog BA, Kuest SM, Husmann L,­Wolfrum M, Goetti R, Buechel RR, Gaemperli O, Luscher TF, Kaufmann PAImpact of cardiac hybrid single-photon emission computed tomography/computed­tomography imaging on choice of treatment strategy in coronary artery disease. Eur­Heart J 2011;32(22):2824–2829

80. Danad I, Raijmakers PG, Appelman YE, Harms HJ, de Haan S, van den Oever ML,­Heymans MW, Tulevski II, van Kuijk C, Hoekstra OS, Lammertsma AA,­Lubberink M, van Rossum AC, Knaapen P. Hybrid imaging using quantitative­H215O PET and CT-based coronary angiography for the detection of coronary­artery disease. J Nucl Med 2013;54(1):55–63

80a. Douglas PS, Garcia MJ, Haines DE, Lai WW, Manning WJ, Patel AR, Picard MH, Polk DM, Ragosta M,Ward RP,Weiner RB. ACCF/ASE/AHA/ASNC/HFSA/HRS/ SCAI/SCCM/SCCT/SCMR 2011 Appropriate Use Criteria for Echocardiography. AReport of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, American Society of Echocardiography, American Heart Association, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, Society of Critical Care Medicine, Society of Cardiovascular Computed Tomography, and Society forCardiovascular Magnetic Resonance Endorsed by the American College of Chest Physicians. J Am Coll Cardiol 2011;57:1126–1166.

81. Schaap J, de Groot JA, Nieman K, Meijboom WB, Boekholdt SM, Post MC, Van der­Heyden JA, de Kroon TL, Rensing BJ, Moons KG, Verzijlbergen JF. Hybrid myocardial­perfusion SPECT/CT coronary angiography and invasive coronary angiography­in patients with stable angina pectoris lead to similar treatment decisions. Heart­2013;99(3):188–194

82. Fiechter M, Ghadri JR, Wolfrum M, Kuest SM, Pazhenkottil AP, Nkoulou RN,­Herzog BA, Gebhard C, Fuchs TA, Gaemperli O, Kaufmann PA. Downstream resource­utilization following hybrid cardiac imaging with an integrated­cadmium-zinc-telluride/64-slice CT device. Eur J Nucl Med Mol Imaging 2012;­39(3):430–436

83. van Werkhoven JM, Heijenbrok MW, Schuijf JD, Jukema JW, van der Wall EE,­Schreur JH, Bax JJ. Combined non-invasive anatomical and functional assessment­with MSCT and MRI for the detection of significant coronary artery disease in­patients with an intermediate pre-test likelihood. Heart 2010;96(6):425–431

84. Ryden L, Grant PJ, Anker SD, Berne C, Cosentino F, Danchin N, Deaton C,­Escaned J, Hammes HP, Huikuri H, Marre M, Marx N, Mellbin L, Ostergren J,­Patrono C, Seferovic P, Uva MS, Taskinen MR, Tendera M, Tuomilehto J,­Valensi P, Zamorano JL, Achenbach S, Baumgartner H, Bax JJ, Bueno H, Dean V,­Erol C, Fagard R, Ferrari R, Hasdai D, Hoes AW, Kirchhof P, Knuuti J, Kolh P,­Lancellotti P, Linhart A, Nihoyannopoulos P, Piepoli MF, Ponikowski P, Sirnes PA,­Tamargo JL, Torbicki A, Wijns W, Windecker S, De Backer G, Ezquerra EA,­Avogaro A, Badimon L, Baranova E, Betteridge J, Ceriello A, Funck-Brentano C,­Gulba DC, Kjekshus JK, Lev E, Mueller C, Neyses L, Nilsson PM, Perk J, Reiner Z,­Sattar N, Schachinger V, Scheen A, Schirmer H, Stromberg A, Sudzhaeva S,­Viigimaa M, Vlachopoulos C, Xuereb RG. ESC Guidelines on diabetes, prediabetes,­and cardiovascular diseases developed in collaboration with the EASD:­the Task Force on diabetes, pre-diabetes, and cardiovascular diseases of the European­Society of Cardiology (ESC) and developed in collaboration with the European­Association for the Study of Diabetes (EASD). Eur Heart J 2013;34(39):­3035–3087

85. Kolh P, Wijns W, Danchin N, Di Mario C, Falk V, Folliguet T, Garg S, Huber K,­James S, Knuuti J, Lopez-Sendon J, Marco J, Menicanti L, Ostojic M, Piepoli MF,­Pirlet C, Pomar JL, Reifart N, Ribichini FL, Schalij MJ, Sergeant P, Serruys PW,­Silber S, Sousa Uva M, Taggart D. Guidelines on myocardial revascularizationEur J Cardiothorac Surg 2010;38 Suppl:S1–S52

86. Wijns W, Kolh P, Danchin N, Di Mario C, Falk V, Folliguet T, Garg S, Huber K,­James S, Knuuti J, Lopez-Sendon J, Marco J, Menicanti L, Ostojic M, Piepoli MF,­Pirlet C, Pomar JL, Reifart N, Ribichini FL, Schalij MJ, Sergeant P, Serruys PW,­Silber S, Sousa Uva M, Taggart D, Vahanian A, Auricchio A, Bax J, Ceconi C,­Dean V, Filippatos G, Funck-Brentano C, Hobbs R, Kearney P, McDonagh T,­Popescu BA, Reiner Z, Sechtem U, Sirnes PA, Tendera M, Vardas PE,­Widimsky P, Alfieri O, Dunning J, Elia S, Kappetein P, Lockowandt U, Sarris G,­Vouhe P, von Segesser L, Agewall S, Aladashvili A, Alexopoulos D, Antunes MJ,­Atalar E, Brutel de la Riviere A, Doganov A, Eha J, Fajadet J, Ferreira R, Garot J,­Halcox J, Hasin Y, Janssens S, Kervinen K, Laufer G, Legrand V, Nashef SA,­Neumann FJ, Niemela K, Nihoyannopoulos P, Noc M, Piek JJ, Pirk J, Rozenman Y,­SabateM, Starc R, Thielmann M, Wheatley DJ,Windecker S, Zembala M. Guidelines­on myocardial revascularization: The Task Force on Myocardial Revascularization­of the European Society of Cardiology (ESC) and the European Association for­Cardio-Thoracic Surgery (EACTS). Eur Heart J 2010;31(20):2501–2555

87. Deb S, Wijeysundera HC, Ko DT, Tsubota H, Hill S, Fremes SE. Coronary artery­bypass graft surgery vs.percutaneous interventions in coronary revascularization:­a systematic review. JAMA 2013;310(19):2086–2095

88. Spertus JA, Salisbury AC, Jones PG, Conaway DG, Thompson RC. Predictors of­quality-of-life benefit after percutaneous coronary intervention. Circulation 2004;­110(25):3789–3794

88a. Cohn PF, Fox KM, Daly C. Silent myocardial ischemia. Circulation 2003;108: 263–1277.

89. Coronary angioplasty vs. medical therapy for angina: the second Randomised Intervention­Treatment of Angina (RITA-2) trial. RITA-2 trial participants. Lancet 1997;­350(9076):461–468

90. Trial of invasive vs. medical therapy in elderly patients with chronic symptomatic­coronary-artery disease (TIME): a randomised trial. Lancet 2001;358(9286):­951–957

90a. Diamond GA,Forrester JS. Analysis of probability as an aid in the clinical diagnosis of coronary-artery disease. N Eng J Med 1979;300:1350–1358.

91. Boden WE, O’Rourke RA, Teo KK, Hartigan PM, Maron DJ, Kostuk WJ,­Knudtson M, Dada M, Casperson P, Harris CL, Chaitman BR, Shaw L,­Gosselin G, Nawaz S, Title LM, Gau G, Blaustein AS, Booth DC, Bates ER,­Spertus JA, Berman DS, Mancini GB, Weintraub WS, Group CTR. Optimal­medical therapy with or without PCI for stable coronary disease. N Engl J Med­2007;356(15):1503–1516

92. Erne P, Schoenenberger AW, Burckhardt D, Zuber M, Kiowski W, Buser PT,­Dubach P, Resink TJ, Pfisterer M. Effects of percutaneous coronary interventions­in silent ischemia after myocardial infarction: the SWISSI II randomized controlled­trial. JAMA 2007;297(18):1985–1991

93. Frye RL, August P, BrooksMM,Hardison RM, Kelsey SF, MacGregor JM, Orchard TJ,­Chaitman BR, Genuth SM, Goldberg SH, Hlatky MA, Jones TL, Molitch ME,­NestoRW, Sako EY, Sobel BE. A randomized trial of therapies for type 2 diabetes­and coronary artery disease. N Engl J Med 2009;360(24):2503–2515

94. Hueb W, Lopes N, Gersh BJ, Soares PR, Ribeiro EE, Pereira AC, Favarato D,­Rocha AS, Hueb AC, Ramires JA. Ten-year follow-up survival of the Medicine,­Angioplasty, or Surgery Study (MASS II): a randomized controlled clinical trial of­3 therapeutic strategies for multivessel coronary artery disease. Circulation 2010;­122(10):949–957

95. Wijeysundera HC, Nallamothu BK, Krumholz HM, Tu JV, Ko DT. Meta-analysis:­effects of percutaneous coronary intervention vs. medical therapy on angina­relief. Ann Intern Med 2010;152(6):370–379

96. Pursnani S, Korley F, Gopaul R, Kanade P, Chandra N, Shaw RE, Bangalore S. Percutaneous­coronary intervention vs. optimal medical therapy in stable coronary­artery disease: a systematic review and meta-analysis of randomized clinical trials Circ Cardiovasc Interv 2012;5(4):476–490

97. Hachamovitch R, Rozanski A, Shaw LJ, Stone GW, Thomson LE, Friedman JD,­Hayes SW, Cohen I, Germano G, Berman DS. Impact of ischaemia and scar on­the therapeutic benefit derived from myocardial revascularization vs. medical­therapy among patients undergoing stress-rest myocardial perfusion scintigraphy Eur Heart J 2011;32(8):1012–1024

98. Sajadieh A, NielsenOW, Rasmussen V, Hein HO, Hansen JF. Prevalence and prognostic­significance of daily-life silent myocardial ischaemia in middle-aged and­elderly subjects with no apparent heart disease. Eur Heart J 2005;26(14):­1402–1409

99. Shaw LJ, Berman DS, Maron DJ, Mancini GB, Hayes SW, Hartigan PM,­Weintraub WS, O’Rourke RA, Dada M, Spertus JA, Chaitman BR, Friedman J,­Slomka P, Heller GV, Germano G, Gosselin G, Berger P, Kostuk WJ,­Schwartz RG, Knudtson M, Veledar E, Bates ER, McCallister B, Teo KK,­Boden WE, Investigators C. Optimal medical therapy with or without percutaneous­coronary intervention to reduce ischemic burden: results from the Clinical­Outcomes Utilizing Revascularization and Aggressive Drug Evaluation­(COURAGE) trial nuclear substudy. Circulation 2008;117(10):1283–1291

100. Stergiopoulos K, Boden WE, Hartigan P, Mobius-Winkler S, Hambrecht R,­HuebW, Hardison RM, Abbott JD, Brown DL. Percutaneous Coronary Intervention­Outcomes in Patients With Stable Obstructive Coronary Artery Disease and­Myocardial Ischemia:ACollaborative Meta-analysis of Contemporary Randomized­Clinical Trials. JAMA Intern Med 2014;174(2):232–240

101. Min JK, Dunning A, Lin FY, Achenbach S, Al-Mallah M, Budoff MJ, Cademartiri F,­Callister TQ, Chang HJ, Cheng V, Chinnaiyan K, Chow BJ, Delago A,­Hadamitzky M, Hausleiter J, Kaufmann P, Maffei E, Raff G, Shaw LJ, Villines T,­Berman DS. Age- and sex-related differences in all-cause mortality risk based on­coronary computed tomography angiography findings results from the International­MulticenterCONFIRM(CoronaryCTAngiography Evaluation for Clinical­Outcomes: An International Multicenter Registry) of 23,854 patients without­known coronary artery disease. J Am Coll Cardiol 2011;58(8):849–860

102. Min JK, Shaw LJ, Devereux RB, Okin PM, Weinsaft JW, Russo DJ, Lippolis NJ,­Berman DS, Callister TQ. Prognostic value of multidetector coronary computed­tomographic angiography for prediction of all-cause mortality. J Am Coll Cardiol­2007;50(12):1161–1170

103. Califf RM, Armstrong PW, Carver JR, D’Agostino RB, Strauss WE. 27th Bethesda­Conference: matching the intensity of risk factor management with the hazard­for coronary disease events. Task Force 5. Stratification of patients into high,­medium and low risk subgroups for purposes of risk factor management. J Am­Coll Cardiol 1996;27(5):1007–1019

103a. Budoff MJ, Dowe D, Jollis JG, Gitter M, Sutherland J, Halamert E, Scherer M, Bellinger R, Martin A, Benton R, Delago A, Min JK. Diagnostic performance of 64-multidetector row coronary computed tomographic angiography for evaluation of coronary artery stenosis in individuals without known coronary artery disease: results from the prospective multicenter ACCURACY (Assessment by Coronary Computed Tomographic Angiography of Individuals Undergoing Invasive Coronary Angiography) trial. J Am Coll Cardiol 2008;52:1724–1732.

104. Prasad A, Rihal CS, Lennon RJ, Singh M, Jaffe AS, Holmes DR Jr. Significance of periprocedural­myonecrosis on outcomes after percutaneous coronary intervention:­an analysis of preintervention and postintervention troponin T levels in 5487­patients. Circ Cardiovasc Interv 2008;1(1):10–19

105. Bangalore S, Pursnani S, Kumar S, Bagos PG. Percutaneous coronary intervention­vs. optimal medical therapy for prevention of spontaneous myocardial infarction in­subjects with stable ischemic heart disease. Circulation 2013;127(7):769–781

106. Hlatky MA, Boothroyd DB, Bravata DM, Boersma E, Booth J, BrooksMM, Carrie D,­Clayton TC, Danchin N, Flather M, Hamm CW, Hueb WA, Kahler J, Kelsey SF,­King SB, Kosinski AS, Lopes N, McDonald KM, Rodriguez A, Serruys P,­Sigwart U, Stables RH,OwensDK, Pocock SJ.Coronary artery bypass surgery compared­with percutaneous coronary interventions for multivessel disease: a collaborative­analysis of individual patient data from ten randomised trials. Lancet 2009;­373(9670):1190–1197

107. Jeremias A, Kaul S, Rosengart TK, Gruberg L, Brown DL. The impact of revascularization­on mortality in patients with nonacute coronary artery disease. Am J Med­2009;122(2):152–161

108. Yusuf S, Zucker D, Peduzzi P, Fisher LD, Takaro T, Kennedy JW, Davis K, Killip T,­Passamani E, Norris R et al. Effect of coronary artery bypass graft surgery on survival:­overview of 10-year results from randomised trials by the Coronary Artery­Bypass Graft Surgery Trialists Collaboration. Lancet 1994;344(8922):563–570

109. Long-term results of prospective randomised study of coronary artery bypass­surgery in stable angina pectoris. European Coronary Surgery Study Group Lancet 1982;2(8309):1173–1180

110. Eleven-year survival in the Veterans Administration randomized trial of coronary­bypass surgery for stable angina. The Veterans Administration Coronary Artery­Bypass Surgery Cooperative Study Group.NEngl J Med 1984;311(21):1333–1339

110a. Tonino PA, De Bruyne B, Pijls NH, Siebert U, Ikeno F, van’ t Veer M, Klauss V, Manoharan G, Engstrom T, Oldroyd KG, Ver Lee PN, MacCarthy PA, Fearon WF. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. N Eng J Med 2009;360:213–224.

111. Myocardial infarction and mortality in the coronary artery surgery study (CASS)­randomized trial. N Engl J Med 1984;310(12):750–758

112. Velazquez EJ, Lee KL, Deja MA, Jain A, Sopko G, Marchenko A, Ali IS, Pohost G,­Gradinac S, Abraham WT, Yii M, Prabhakaran D, Szwed H, Ferrazzi P, Petrie MC,­O’Connor CM, Panchavinnin P, She L, Bonow RO, Rankin GR, Jones RH,­Rouleau JL. Coronary-artery bypass surgery in patients with left ventricular dysfunction N Engl J Med 2011;364(17):1607–1616

113. Pitt B, Waters D, Brown WV, van Boven AJ, Schwartz L, Title LM, Eisenberg D,­Shurzinske L, McCormick LS. Aggressive lipid-lowering therapy compared with­angioplasty in stable coronary artery disease. Atorvastatin vs. Revascularization­Treatment Investigators. N Engl J Med 1999;341(2):70–76

Не нашли, что искали? Воспользуйтесь поиском: